Therapy of Atrial Flutter by Afib Ablation

• Status: Unknown status
• Trial end date: 2017-08-01
• Target enrollment: 0
• Participant gender: All

Summary

Ablation of the cavotricuspid isthmus (CTI) in the right atrium is currently the therapy of choice for the treatment of typical atrial flutter (3,4). It is a curative approach and has a high success rate (5). It has been recognized that patients with typical atrial flutter often complain of atrial fibrillation (1,2). Current clinical and experimental studies confirm the close relationship between atrial flutter (AFL) and atrial fibrillation (AF) and raise a question, if both arrhythmias are different forms of a common electrical phenomenon with atrial fibrillation being the underlying clinical problem (6).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Rostock
• Collaborators: Biosense Webster, Inc.; Medtronic
• Treatments: Anti-Arrhythmia Agents

Criteria

Inclusion Criteria:

• Patients with- in 12-Channel-ECG documented atrial tachycardia suggestive of typical isthmus dependent atrial flutter

• > 21 years

Exclusion Criteria:

• - AFL as secondary to an accessory pathway

• Antiarrhythmic treatment for AF

• AF

• Previous AF ablation

• Dilatation of left atrium > 6 cm

• Cardiac surgery less < 3 weeks

• Congenital heart disease

• Cardiac ischemia or coronary artery disease that needs intervention

• Life expectancy less than 2 years